License Agreement Turns Biotech Partners Into Rivals
Biotech partners in a transatlantic licensing dispute are on their way to arbitration after California's Spectrum Pharmaceuticals Inc. accused its German partner of cutting it out of a multimillion dollar sublicensing...To view the full article, register now.
Already a subscriber? Click here to view full article